Inderes’s Q4 report was well in line with our forecast and we highlight the improved activity in the...
Q4 showed a long-awaited return to organic growth driven by sales in Europe, while sales in the Amer...
Xer Tech är ett UAV-bolag som utvecklar och säljer hybridelektriska drönarsystem för tunga lyft och ...
Nettoomsättningen steg till 7 750 mkr med 4% organisk tillväxt och sex nya förvärv, inklusive intåg ...
Actic has delivered an impressive turnaround, driven by good execution and greater efficiency.
Redeye leaves a short comment following Cinclus’ announcement of having received positive CMC feedba...
Solteq reports Q4 figures on February 12. Despite a December guidance cut and change negotiations an...
Aspo reports Q4 results on Feb 16. ESL should see more significant earnings gains from now on as out...
Redeye provides an initial comment on the Q4 2025 report from Sdiptech, where adjusted EBITA in core...
* Sales -5% vs ABG, adj. EBITA +23% on lower opex * West and Central continue to struggle, UK positi...
Nelly Group Q4 report was solid but mixed, with net sales of SEK 371m, up 16% y/y (5% ahead of SEB),...
Redeye returns with an update following Ascelia Pharma's Q4 update, which contained no material surp...
Enersense and Finnish energy company Helen have agreed to extend their operations and maintenance ag...
Redeye comments on Hacksaw ahead of Q4-results (due 17 February) where we expect continued solid gro...
Relais outperformed the market in Q3 and we expect a similar performance for Q4.
The Leipurin segment was divested in August 2025 and ESL Shipping could be sold this year.
Redeye provides a preview of Catella ahead of the company's Q4 2025 results, scheduled for 17 Februa...
* We expect broad-based organic growth * Q4e net sales of SEK 193m, EBITA of SEK 25m * We reiterate ...
* Q4 EBITDA of NOK 5m * Awaiting improved markets * '26e-'27e estimates down – fair value range of N...
We expect a noticeable improvement in Gofore’s margin performance in Q4.
